Remove 2013 Remove Chronic Pain Remove Collective Remove Treatment
article thumbnail

Guest Post: The Legal Status of CBD Oil in Italy

Cannabis Law Report

While the Ministries of Health and Justice awarded penalties for the possession, sale and consumption of cannabis prior to 2013, medical cannabis was legalised and made available to patients from 2013 onwards. Chronic pain. Nausea – induced by chemotherapy, radiation therapy and treatment for AIDS/HIV. Adult acne.

Oil 63
article thumbnail

The Endocannabinoid System: Here’s How it Keeps You Healthy and Happy

Greencamp

Nonetheless, the available collection of scientific work confirms that consuming cannabis-derived cannabinoids (phytocannabinoids) compels our body to produce more (endo)cannabinoid receptors, but also to create more endocannabinoids. Chronic Pain. This survey from 2013 was conducted by the Medical Cannabis Evaluation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). Data collection.

article thumbnail

Drastic Increase in Scientific Research on Medicinal Cannabis

Sensi Seeds

The authors of the paper have used specialized Internet databases such as PubMed and Web of Science to try and collect all the cannabis publications that have been released since 2000, and to analyse trends in scientific publications that focus on cannabis. ” An Encouraging Increase.

article thumbnail

Dentons’ Cannabis Group Latest Weekly Update – June 2019 #4

Cannabis Law Report

The House also included amendments transferring $5 million from the Drug Enforcement Administration to opioid treatment programs, and directing the Food and Drug Administration to establish regulations for adding CBD to food and dietary supplements. The panel also took up a bill sponsored by Rep. Medical / Health.